2025 CERSI Innovations in Regulatory Science Summit: Regulatory Frontiers in Healthcare Innovation
Sunday, January 12 at 9:00 am
-
6:00 pm
Add to Calendar
2025-01-12 09:00:00
2025-01-12 18:00:00
2025 CERSI Innovations in Regulatory Science Summit: Regulatory Frontiers in Healthcare Innovation
The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the sixth annual CERSI Innovations in Regulatory Science Summit, a gathering of leaders in the academia, industry, and regulatory sectors to discuss the role of regulatory science in medical product development.
The 2025 CERSI Innovations in Regulatory Science Summit will highlight the latest developments in regulatory science, with a particular focus on generative artificial intelligence and women’s health. Additionally, we’re excited to announce the return of our engaging panels with former FDA Commissioners who will explore the current challenges the Agency is facing. The FDA Center Directors panel will also make a comeback, alongside a series of stimulating debates on key issues in regulatory science.
The goal of the summit is to stimulate discussion across sectors and to critically consider lessons learned and scientific issues that need addressing to expeditiously and safely advance the development, approval, and monitoring of medical products.
1675 Owens Street
Mission Bay Conference Center at UCSF
San Francisco, CA 94158
United States
View on Map
[email protected]
America/Los_Angeles
public
1675 Owens Street
Mission Bay Conference Center at UCSF
San Francisco, CA 94158
United States
View on Map
The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the sixth annual CERSI Innovations in Regulatory Science Summit, a gathering of leaders in the academia, industry, and regulatory sectors to discuss the role of regulatory science in medical product development.
The 2025 CERSI Innovations in Regulatory Science Summit will highlight the latest developments in regulatory science, with a particular focus on generative artificial intelligence and women’s health. Additionally, we’re excited to announce the return of our engaging panels with former FDA Commissioners who will explore the current challenges the Agency is facing. The FDA Center Directors panel will also make a comeback, alongside a series of stimulating debates on key issues in regulatory science.
The goal of the summit is to stimulate discussion across sectors and to critically consider lessons learned and scientific issues that need addressing to expeditiously and safely advance the development, approval, and monitoring of medical products.